Autoimmune haemolytic anaemia and antiphospholipid antibodies in paediatrics: a systematic review and meta-analysis
| dc.contributor.author | Merashli, Mira | |
| dc.contributor.author | Arcaro, Alessia | |
| dc.contributor.author | Graf, Maria | |
| dc.contributor.author | Gentile, Fabrizio | |
| dc.contributor.author | Ames, Paul R.J. | |
| dc.contributor.department | Internal Medicine | |
| dc.contributor.department | Rheumatology | |
| dc.contributor.faculty | Faculty of Medicine (FM) | |
| dc.contributor.institution | American University of Beirut | |
| dc.date.accessioned | 2025-01-24T11:43:15Z | |
| dc.date.available | 2025-01-24T11:43:15Z | |
| dc.date.issued | 2021 | |
| dc.description.abstract | Introduction/objective: The relationship between autoimmune haemolytic anaemia (AIHA) and antiphospholipid antibodies (aPL) has never been addressed via a meta-analysis in the paediatric age group. We evaluated the link between AIHA and aPL in childhood systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS). Methods: EMBASE and PubMed were screened from inception to May 2020 and Peto’s odds ratio for rare events was employed for the between group comparisons. Results: The meta-analysis included 11 articles for a total of 575 children: the pooled prevalence of AIHA was greater in (1) IgG aCL–positive than IgG aCL–negative children (39.7% vs 20.9%, p = 0.005); (2) in APS-positive than APS-negative SLE children (36.8% vs 13.2%, p = 0.01); and (3) in SLE-related APS than in primary APS children (53% vs 16.2%, p = 0.008). Conclusions: The pooled prevalence of AIHA is greatest in SLE with aPL/APS, low-moderate in SLE without aPL/APS, and lowest in primary APS.Key Points• Antiphospholipid antibodies strongly relate to autoimmune haemolytic anaemia.• Autoimmune haemolytic anaemia is more common in systemic lupus erythematosus with antiphospholipid antibodies. © 2020, International League of Associations for Rheumatology (ILAR). | |
| dc.identifier.doi | https://doi.org/10.1007/s10067-020-05436-2 | |
| dc.identifier.eid | 2-s2.0-85091737949 | |
| dc.identifier.pmid | 33006737 | |
| dc.identifier.uri | http://hdl.handle.net/10938/30246 | |
| dc.language.iso | en | |
| dc.publisher | Springer Science and Business Media Deutschland GmbH | |
| dc.relation.ispartof | Clinical Rheumatology | |
| dc.source | Scopus | |
| dc.subject | Antiphospholipid syndrome | |
| dc.subject | Autoimmune haemolytic anaemia | |
| dc.subject | Lupus | |
| dc.subject | Anemia, hemolytic, autoimmune | |
| dc.subject | Antibodies, antiphospholipid | |
| dc.subject | Child | |
| dc.subject | Humans | |
| dc.subject | Lupus erythematosus, systemic | |
| dc.subject | Pediatrics | |
| dc.subject | Immunoglobulin g | |
| dc.subject | Phospholipid antibody | |
| dc.subject | Adolescent | |
| dc.subject | Article | |
| dc.subject | Autoimmune hemolytic anemia | |
| dc.subject | Cohort analysis | |
| dc.subject | Coombs test | |
| dc.subject | Female | |
| dc.subject | Follow up | |
| dc.subject | Human | |
| dc.subject | Male | |
| dc.subject | Meta analysis | |
| dc.subject | Prevalence | |
| dc.subject | Priority journal | |
| dc.subject | Protein expression | |
| dc.subject | Systematic review | |
| dc.subject | Systemic lupus erythematosus | |
| dc.subject | Complication | |
| dc.title | Autoimmune haemolytic anaemia and antiphospholipid antibodies in paediatrics: a systematic review and meta-analysis | |
| dc.type | Article |
Files
Original bundle
1 - 1 of 1